Find comprehensive information on lung carcinoma, including clinical documentation, medical coding (ICD-10-CM codes C34.00-C34.92), staging (TNM classification), and histology. Learn about lung cancer diagnosis, treatment options, and best practices for healthcare professionals. Explore resources for accurate medical record keeping, coding compliance, and improving patient care related to lung carcinoma.
Also known as
Malignant neoplasm of bronchus and lung
Cancers originating in the bronchi and lungs.
Secondary malignant neoplasm of lung
Cancer that has spread to the lungs from another site.
Secondary malignant neoplasm of respiratory system
Cancer spread to respiratory system, unspecified site.
Personal history of malignant neoplasm
History of cancer, including lung cancer, now in remission.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the lung carcinoma malignant?
Yes
Is histology documented?
No
Carcinoma in situ?
When to use each related code
Description |
---|
Lung cancer |
Lung carcinoid tumor |
Metastatic lung cancer |
Lack of specific histology documentation for lung carcinoma subtypes (e.g., adenocarcinoma, squamous cell) impacts accurate coding and reimbursement.
Incomplete staging data (TNM) affects proper code assignment and may trigger audits for insufficient documentation.
Missing or unclear documentation of laterality (right/left lung) leads to coding errors and potential claim denials.
Patient presents with complaints consistent with possible lung carcinoma. Symptoms include persistent cough, hemoptysis, dyspnea, chest pain, unexplained weight loss, and fatigue. Patient history includes a significant smoking history of X pack-years. Physical examination reveals decreased breath sounds and dullness to percussion in the right upper lung field. Differential diagnosis includes pneumonia, bronchitis, and tuberculosis. Preliminary imaging studies, including chest X-ray and CT scan of the chest, suggest a mass in the right upper lobe, raising suspicion for lung cancer. Further investigation with bronchoscopy and biopsy is scheduled to confirm the diagnosis and determine histological subtype (e.g., small cell lung cancer, non-small cell lung cancer adenocarcinoma, squamous cell carcinoma). Staging workup, including PET scan and possible mediastinoscopy, will be performed upon confirmation of malignancy to assess extent of disease and guide treatment planning. Treatment options will be discussed with the patient following the completion of diagnostic testing and may include surgery (lobectomy, pneumonectomy), chemotherapy, radiation therapy, targeted therapy, or immunotherapy, depending on the stage and type of lung cancer. Patient education regarding smoking cessation, palliative care, and clinical trial options will be provided. ICD-10 code C34.90 (malignant neoplasm of unspecified part of unspecified bronchus or lung) is provisionally assigned, pending definitive diagnosis. CPT codes for procedures performed will be documented accordingly. Oncology consult requested. Follow-up scheduled in one week to review biopsy results and discuss treatment plan.